XERIS BIOPHARMA HOLDINGS, INC. (XERS) Shareholders’ equity 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) shareholders’ equity at each fiscal year-end, per SEC filings.
$13.7MFY2025 · since FY2020: $33.8M → $13.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.7M | +146.2% |
| FY2024 | -$29.6M | -336.7% |
| FY2023 | -$6.8M | -115.0% |
| FY2022 | $45.2M | -52.6% |
| FY2021 | $95.2M | +182.1% |
| FY2020 | $33.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice